ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.235,45
0,17%
S&P 500
5.457,99
-0,45%
Dow Jones
38.976,36
-0,48%
Euro vs US Dollar
1,07113
0,03%
Bitcoin
60.184,14
-2,32%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Nexalin Technologies Inc (NXLIW)

  7. Nexalin Technologies Inc (NXLIW) News

NXLIW

Nexalin Technologies (NXLIW)

Nexalin Technologies Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NXLIW
DatumZeitQuelleÜberschriftSymbolFirma
28/06/202403h15GlobeNewswire Inc.Nexalin Technology Announces Pricing of $5.2 Million Public OfferingNASDAQ:NXLIWNexalin Technologies Inc
26/06/202415h00GlobeNewswire Inc.Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific JournalNASDAQ:NXLIWNexalin Technologies Inc
20/06/202414h30GlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and DementiaNASDAQ:NXLIWNexalin Technologies Inc
18/06/202423h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
14/06/202415h53Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NXLIWNexalin Technologies Inc
13/06/202421h00GlobeNewswire Inc.Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)NASDAQ:NXLIWNexalin Technologies Inc
12/06/202419h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
04/06/202414h30GlobeNewswire Inc.Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6thNASDAQ:NXLIWNexalin Technologies Inc
03/06/202414h30GlobeNewswire Inc.FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset DeviceNASDAQ:NXLIWNexalin Technologies Inc
23/05/202423h17Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:NXLIWNexalin Technologies Inc
22/05/202414h30GlobeNewswire Inc.Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research EffortsNASDAQ:NXLIWNexalin Technologies Inc
21/05/202422h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
14/05/202422h54Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:NXLIWNexalin Technologies Inc
10/05/202420h50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXLIWNexalin Technologies Inc
09/05/202414h30GlobeNewswire Inc.Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23NASDAQ:NXLIWNexalin Technologies Inc
25/04/202416h44GlobeNewswire Inc.Nexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:NXLIWNexalin Technologies Inc
09/04/202414h30GlobeNewswire Inc.Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical TestingNASDAQ:NXLIWNexalin Technologies Inc
04/04/202419h00GlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation DeviceNASDAQ:NXLIWNexalin Technologies Inc
02/04/202414h30GlobeNewswire Inc.Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory BoardNASDAQ:NXLIWNexalin Technologies Inc
28/03/202413h30GlobeNewswire Inc.Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San DiegoNASDAQ:NXLIWNexalin Technologies Inc
14/03/202413h30GlobeNewswire Inc.Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s TechnologyNASDAQ:NXLIWNexalin Technologies Inc
13/03/202413h30GlobeNewswire Inc.Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”NASDAQ:NXLIWNexalin Technologies Inc
08/02/202414h30GlobeNewswire Inc.Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation DeviceNASDAQ:NXLIWNexalin Technologies Inc
23/01/202414h30GlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) SystemNASDAQ:NXLIWNexalin Technologies Inc
11/01/202414h30GlobeNewswire Inc.Nexalin Technology Unveils Next-Generation HALO™ ClarityNASDAQ:NXLIWNexalin Technologies Inc
18/12/202314h30GlobeNewswire Inc.Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant DepressionNASDAQ:NXLIWNexalin Technologies Inc
25/10/202314h30GlobeNewswire Inc.Nexalin Technology Announces Formation of New Military & Government Advisory Board to be Led by Government Affairs Veteran David LasseterNASDAQ:NXLIWNexalin Technologies Inc
16/10/202314h30GlobeNewswire Inc.Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin’s Neurostimulation Device to Penetrate Deep Brain StructuresNASDAQ:NXLIWNexalin Technologies Inc
07/08/202314h30GlobeNewswire Inc.Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related SymptomsNASDAQ:NXLIWNexalin Technologies Inc
03/08/202314h30GlobeNewswire Inc.Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern TimeNASDAQ:NXLIWNexalin Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:NXLIW

Kürzlich von Ihnen besucht

DBI
DAX
DAX
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
CCOM
US100
US Tech 100
TG
432
Arbor Metals
CCOM
SILVER
SILVER
NASDAQ
TSLA
Tesla
NYSE
NKE
Nike
USOTC
RHHBY
Roche (QX)
DBI
MDAX
MDAX
USOTC
ADDYY
Adidas (QX)
AMEX
SPY
SPDR S&P 500
TG
DBK
Deutsche Bank
NYSE
JPM
JP Morgan Chase
AMEX
XLE
Energy Select Sector SPDR
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten